Table 1

Lipid and hematologic parameters in apoE−/− mice treated with PRT060318

ParameterVehicle control (n = 4)PRT060318 (n = 5)P
Lipids    
    Total cholesterol, mg/dL 334 ± 64 378 ± 96 0.44 
    LDL cholesterol, mg/dL 319 ± 61 334 ± 64 0.58 
    Triglycerides, mg/dL 44 ± 16 51 ± 11 0.48 
CBC    
    WBC, no./μL × 103 3.7 ± 1.1 3.8 ± 1.4 0.94 
    Hemoglobin, g/L 10.8 ± 2.1 12.4 ± 1.9 0.25 
    Platelet count, no./μL × 103 577 ± 297 480 ± 136 0.58 
ParameterVehicle control (n = 4)PRT060318 (n = 5)P
Lipids    
    Total cholesterol, mg/dL 334 ± 64 378 ± 96 0.44 
    LDL cholesterol, mg/dL 319 ± 61 334 ± 64 0.58 
    Triglycerides, mg/dL 44 ± 16 51 ± 11 0.48 
CBC    
    WBC, no./μL × 103 3.7 ± 1.1 3.8 ± 1.4 0.94 
    Hemoglobin, g/L 10.8 ± 2.1 12.4 ± 1.9 0.25 
    Platelet count, no./μL × 103 577 ± 297 480 ± 136 0.58 

PRT060318 (30 mg/kg in distilled water) or vehicle control was administered via oral gavage twice daily for 3 weeks followed by 1 week off, for a total of 16 weeks.

LDL indicates low-density lipoprotein; CBC, complete blood count; WBC, white blood cells; PMN, neutrophils; and HCT, hematocrit.

Close Modal

or Create an Account

Close Modal
Close Modal